Metabolomics

Dataset Information

0

Integrated analysis of therapeutic efficacy and resistance mechanisms of lytic phages targeting ST218 K57 CR-hvKp


ABSTRACT: Clinical infection caused by carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) is gradually increasing and spreading across the world, and phage therapy is a viable application as an alternative to antibiotics. However, additional clinical application is still restricted by the phage resistance. In order to further explore the mechanism of phage resistance, particularly the difference between in vivo and in vitro. Here, we used a mouse intra-abdominal infection (IAI) model to evaluate the antibacterial properties of two lytic phages and further isolated and characterized phage-resistant mutants. Finally, we determined through genomic and transcriptomic analysis that most of the mutation sites in the resistant mutants were located in the capsular polysaccharides gene cluster. However, RM01 and RM12 developed phage resistance by downregulating capsular polysaccharide (CPS) and its transcriptional regulators without any mutations in the CPS gene. In summary, these findings provided further evidence in phage therapy, particularly in addressing the issue of CR-hvKP infections.

INSTRUMENT(S): Liquid Chromatography MS - positive - hilic, Liquid Chromatography MS - negative - hilic

PROVIDER: MTBLS12480 | MetaboLights | 2025-09-18

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
NEG_JLKP186_1.raw Raw
NEG_JLKP186_2.raw Raw
NEG_JLKP186_3.raw Raw
NEG_JLKP186_4.raw Raw
NEG_JLKP186_5.raw Raw
Items per page:
1 - 5 of 50

Similar Datasets

2024-10-01 | GSE272297 | GEO
2025-09-16 | GSE307523 | GEO
2025-12-15 | MTBLS13411 | MetaboLights
2025-10-01 | GSE308794 | GEO
2025-07-02 | MSV000098411 | MassIVE
2025-12-09 | GSE291879 | GEO
2021-11-25 | PXD028544 | Pride
2020-07-01 | GSE153553 | GEO
2021-04-26 | GSE140840 | GEO
2021-09-04 | PXD028206 | JPOST Repository